Health Care

Mankind Pharma Q3 FY26 Earnings Results

● Feb 3, 2026

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and...

Artemis Medicare Services Posts 17% Revenue Growth in Q3 FY26 Amid Aggressive Multi-City Expansion

● Feb 3, 2026

Artemis Medicare Services Ltd. (NSE:ARTEMISMED;BSE:542919), a leading multi-specialty healthcare provider in India, reported a robust financial performance for the third...

Artemis Medicare Q3 profit rises on higher overseas patient inflows, steady margins

● Feb 2, 2026

Artemis Medicare Services Ltd (NSE:ARTEMISMED), a leading healthcare provider operating 800+ beds, anchored by a quaternary care, super-specialty hospital, reported...

GPT Healthcare posts higher nine-month revenue but lower margins in Q3 FY26

● Feb 2, 2026

GPT Healthcare Ltd (BSE: 544131 / NSE: GPTHEALTH) reported higher revenue but lower profitability in the quarter ended December 31,...

Sun Pharmaceutical Q3 FY26 Earnings Results

● Feb 2, 2026

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and...

Aster DM Healthcare Q3 Revenue Rises 13% as Company Advances QCIL Merger Integration

● Feb 2, 2026

Aster DM Healthcare Limited (NSE: ASTERDM) the healthcare provider reported consolidated revenue of ₹1,185.76 crore for the quarter ended December...

Aster DM Healthcare Q3 FY26 Results: Revenue Rises 13% YoY as Margins Improve Sequentially; Profitability Moderated by Exceptional Costs

● Feb 2, 2026

Aster DM Healthcare Limited (NSE: ASTERDM) reported consolidated revenue from operations of ₹1,186 crore for the quarter ended December 31,...

Glenmark Pharmaceuticals Q3 FY26 Revenue Rises 15.1% on Strong Domestic and North American Growth

● Feb 2, 2026

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) reported consolidated revenue of ₹39,006 million for the third quarter ended December 31, 2025, a...

Glenmark Rallies as Q3 Margins Expand, FDA Clears U.S. Facility

● Feb 2, 2026

Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) The Mumbai-based pharmaceutical company posts strong domestic and international sales as it transitions toward an...

Jupiter Life Line Hospitals: Scaling Towards a 2,500-Bed Future

● Feb 2, 2026

Jupiter Life Line Hospitals Limited (NSE: JLHL, BSE: 543980) continues to strengthen its position in the Indian healthcare sector, driven...